Loading...

2,281 posters, 63 videos, 56 audios, 43 topics, 18 sessions, 6,174 authors, 2,323 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

RCOG World Congress 2025

June 23 - 25, 2025 | ExCeL London, UK

EP.0335

Impact of Medical and Surgical Management on ovarian reserve in Endometriosis

Part of Topic

Endometriosis & uterine disorders

Impact Of Medical And Surgical Management On Ovarian Reserve In Women

With Endometriosis As Measured By Anti-Mullerian Hormone (AMH) And Inhibin B

Objective

To assess the impact of medical and surgical treatment on ovarian reserve in women with endometriosis as assessed by Anti-Mullerian Hormone (AMH) and Inhibin B (IB) levels

Design:

Prospective observational case-control study of women treated with endometriosis medically and surgically in a tertiary care center in Oman.

 

Methods:

From April 2021 to June 2023, women referred to gynecologic clinic with suspected endometriosis were invited to participate with an informed consent. They underwent AMH, IB and cycle day 2-4 FSH at entry (T0). They were managed as per standards of care and as agreed between the woman and her treating team. Serum IB and AMH were then repeated at 4 (T1) and 12 (T2) weeks from the start of the medical therapy or post-operatively if underwent surgery for endometriosis.

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.